[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570770":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":17,"locations":22,"responsibleParty":38,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":7,"maxAge":7,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":7,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Shandong University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DRUG","Anti-Infective Drugs","Anti-infective drugs are administered using the traditional clinical dosing regimen, with no interventions.",[14],{"name":15,"affiliation":5,"role":16},"Wei Zhao, Ph.D","PRINCIPAL_INVESTIGATOR",[18],{"name":15,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","86053188383308","zhao4wei2@hotmail.com",[23],{"facility":24,"status":25,"city":26,"state":7,"zip":7,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Shandong Public Health Clinical Center","RECRUITING","Jinan","China","CN",{"type":30,"coordinates":31},"Point",[32,33],116.99722,36.66833,{"lat":33,"lon":32},[36],{"name":37,"role":19,"phone":7,"phoneExt":7,"email":7},"Qiang Zhang",{"type":16,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Wei Zhao","Head of department of clinical pharmacy and pharmacology","100570770","model-informed-individualized-treatment-of-anti-infective-drugs-100570770",false,"NCT06711562","Model-informed Individualized Treatment of Anti-infective Drugs","Model-informed Individualized Treatment of Anti-infective Drugs in Patients With Osteoarticular Infections","Inclusion Criteria:\n\n* Patients with suspected\u002Fconfirmed osteoarticular infections who are undergoing anti-infective drug therapy.\n\nExclusion Criteria:\n\n* Pregnant\u002Flactating women.\n* There are other factors that the researchers think are not suitable for inclusion.","ALL",{"count":50,"type":51},300,"ESTIMATED","OBSERVATIONAL","The study aims to optimize individualized treatment of anti-infective drugs in osteoarticular infections by analyzing drug exposure in patients blood and\u002For tissues using population pharmacokinetics.",[55],"Osteoarticular Infections","2024-11-29",{"date":58,"type":59},"2024-12-02","ACTUAL",{"date":61,"type":59},"2024-10-12",{"date":63,"type":51},"2026-10-01",{"name":5,"class":6},1]